home / stock / prph / prph quote
Last: | $4.95 |
---|---|
Change Percent: | 0.0% |
Open: | $5.06 |
Close: | $4.95 |
High: | $5.2277 |
Low: | $4.9 |
Volume: | 12,151 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.95 | $5.06 | $4.95 | $5.2277 | $4.9 | 12,151 | 04-25-2024 |
$5.06 | $5.17 | $5.06 | $5.46 | $5.05 | 15,554 | 04-24-2024 |
$5.16 | $4.89 | $5.16 | $5.3911 | $4.89 | 16,630 | 04-23-2024 |
$4.9 | $5.17 | $4.9 | $5.17 | $4.9 | 62,107 | 04-22-2024 |
$5.26 | $5.31 | $5.26 | $5.31 | $5.05 | 99,267 | 04-19-2024 |
$5.44 | $6.32 | $5.44 | $6.32 | $5.33 | 1,176,783 | 04-18-2024 |
$6.27 | $7.47 | $6.27 | $7.47 | $6.051 | 83,037 | 04-17-2024 |
$7.35 | $6.54 | $7.35 | $7.48 | $6.27 | 190,036 | 04-16-2024 |
$6.155 | $6.63 | $6.155 | $6.77 | $6.115 | 48,030 | 04-15-2024 |
$6.52 | $6.58 | $6.52 | $6.64 | $6.291 | 27,388 | 04-12-2024 |
$6.4 | $6.6 | $6.4 | $6.6999 | $6.18 | 83,174 | 04-11-2024 |
$6.13 | $6.04 | $6.13 | $6.22 | $6.005 | 19,140 | 04-10-2024 |
$6.1 | $6.61 | $6.1 | $6.6417 | $6.06 | 26,633 | 04-09-2024 |
$6.6 | $6.88 | $6.6 | $6.88 | $6.5 | 35,748 | 04-08-2024 |
$6.8 | $6.67 | $6.8 | $6.9162 | $6.67 | 45,638 | 04-05-2024 |
$6.58 | $6.64 | $6.58 | $6.75 | $6.5032 | 21,742 | 04-04-2024 |
$6.62 | $6.8 | $6.62 | $6.88 | $6.42 | 37,479 | 04-03-2024 |
$6.89 | $6.95 | $6.89 | $6.96 | $6.76 | 50,253 | 04-02-2024 |
$6.85 | $6.59 | $6.85 | $6.93 | $6.54 | 33,474 | 04-01-2024 |
$6.47 | $6.46 | $6.47 | $6.55 | $6.2273 | 16,102 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm ES...
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company...
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the commercialization of its breakthrough BE-Smart test fo...